Case Reports in Oncological Medicine最新文献

筛选
英文 中文
Atezolizumab-Induced Sarcoidosis-Like Reaction in a Patient with Metastatic Breast Cancer. 阿特唑单抗诱导转移性乳腺癌患者结节病样反应
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2022-01-27 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2709062
Akira Tsunoda, Toshiro Mizuno, Shohei Iida, Katsunori Uchida, Masako Yamashita, Koshi Sukeno, Hiroki Oka, Yasutaka Tono, Mikiya Ishihara, Kanako Saito, Satoshi Tamaru, Keiichi Yamanaka, Isao Tawara
{"title":"Atezolizumab-Induced Sarcoidosis-Like Reaction in a Patient with Metastatic Breast Cancer.","authors":"Akira Tsunoda,&nbsp;Toshiro Mizuno,&nbsp;Shohei Iida,&nbsp;Katsunori Uchida,&nbsp;Masako Yamashita,&nbsp;Koshi Sukeno,&nbsp;Hiroki Oka,&nbsp;Yasutaka Tono,&nbsp;Mikiya Ishihara,&nbsp;Kanako Saito,&nbsp;Satoshi Tamaru,&nbsp;Keiichi Yamanaka,&nbsp;Isao Tawara","doi":"10.1155/2022/2709062","DOIUrl":"https://doi.org/10.1155/2022/2709062","url":null,"abstract":"<p><p>Tumor-related sarcoidosis-like reactions (SLR) have been reported with the use of immune checkpoint inhibitors (ICIs). We report a case of 50-year-old woman who observed an enlarged lymph node in the right hilar region and the appearance of a subcutaneous mass in the extremities during chemotherapy with atezolizumab plus nab-paclitaxel for metastatic triple-negative breast cancer (TNBC). Skin biopsy revealed the formation of epithelioid granulation species with the Langhans giant cell. After discontinuing atezolizumab in the treatment procedure, the hilar lymph nodes and the subcutaneous mass were reduced. A pathological examination was effective in differentiating tumor exacerbation from SLR. Owing to limited information on ICI-related SLR in breast cancer, future studies are recommended to properly manage immune-related adverse effects during cancer treatment.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":" ","pages":"2709062"},"PeriodicalIF":0.9,"publicationDate":"2022-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39756925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Primary Eccrine Porocarcinoma of the Breast: A Case Report and Review of Literature. 乳腺原发性内分泌性多孔癌1例报告及文献复习。
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2022-01-01 DOI: 10.1155/2022/4042298
Yi Xin Li, Mihir Gudi, Zhiyan Yan
{"title":"Primary Eccrine Porocarcinoma of the Breast: A Case Report and Review of Literature.","authors":"Yi Xin Li,&nbsp;Mihir Gudi,&nbsp;Zhiyan Yan","doi":"10.1155/2022/4042298","DOIUrl":"https://doi.org/10.1155/2022/4042298","url":null,"abstract":"<p><p>Eccrine porocarcinoma (EPC) is a rare cutaneous neoplasm, with less than 500 reported cases worldwide since it was first described in 1963. EPC tends to affect the elderly and most commonly affects the head and neck. The mainstay of EPC treatment is surgery, with lymphadenectomy in the case of nodal involvement or presence of unfavourable characteristics. No evidence exists to guide the use of adjuvant chemotherapy or radiation. EPC is prone to misdiagnosis given its multiple clinical and histopathological mimics, especially in uncommon sites of presentation such as the breast. Herein, we report the case of a 59-year-old woman who presented with a left breast skin lump. The biopsied specimen revealed an infiltrative carcinoma involving the dermis and epidermis with positive IHC staining for P63 and CK5/6 and negative staining for ER, PR, and HER2. The tumour was resected and diagnosed as EPC with atypical features as overlapping characteristics of squamous cell carcinoma (SCC) were detected on histopathological analysis. In our case, a simple mastectomy with broad margins and axillary lymph node dissection with adjuvant radiotherapy to a dose of 60 Gy failed to achieve loco-regional control with nodal recurrence occurring 4 months postsurgery-a testament to the aggressive course of this rare malignancy.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2022 ","pages":"4042298"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10257503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient. 黑色素瘤患者辅助抗pd -1免疫检查点抑制剂治疗继发嗜酸性哮喘
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2022-01-01 DOI: 10.1155/2022/2658136
P Kissoonsingh, B Sutton, Syed U Iqbal, Lalit Pallan, Neil Steven, L Khoja
{"title":"Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient.","authors":"P Kissoonsingh,&nbsp;B Sutton,&nbsp;Syed U Iqbal,&nbsp;Lalit Pallan,&nbsp;Neil Steven,&nbsp;L Khoja","doi":"10.1155/2022/2658136","DOIUrl":"https://doi.org/10.1155/2022/2658136","url":null,"abstract":"<p><strong>Background: </strong>Adjuvant immune checkpoint inhibitors are a new standard of care in melanoma. However, the immune related toxicity associated with these agents can be serious, and the long-term implications are yet to be defined especially in the adjuvant setting. We report, to our knowledge, the first case of anti-PD-1-induced eosinophilic asthma in a melanoma patient treated with adjuvant pembrolizumab. <i>Case Presentation.</i> A 72-year-old man commenced pembrolizumab in the adjuvant setting after resection of a stage IIIB cutaneous melanoma. The patient experienced episodes of breathlessness 4 weeks after cycle 1. These episodes were nocturnal and caused acute respiratory distress and cough, occasionally waking him up. The episodes progressed, and he was admitted after cycle 2 with a productive cough, wheeze, and breathlessness. Observations showed saturations on air of 94% and a respiratory rate of 19/min. The only laboratory abnormality was a raised eosinophil count of 1.1 × 10<sup>9</sup>. Spirometry showed a FEV1 of 2.57 (91% predicted), FVC of 4.04 (108% predicted), and ratio of 64%. Peak expiratory flow rate was 94% predicted, and corrected gas transfer was 6.29 (78% predicted) with KCO 1.18 (93% predicted). FeNO was raised at 129 indicating inflammation of his airways, and peak flow was 422 l/min. CT of the chest did not show pneumonitis or other lung pathology. A diagnosis of acute eosinophilic asthma was made. Treatment with steroids and beclometasone dipropionate and formoterol inhaler produced rapid resolution of symptoms and normalisation of the eosinophil count. Pembrolizumab was safely recommenced once steroids had discontinued and symptoms had resolved.</p><p><strong>Conclusions: </strong>Specialist respiratory input was needed for optimal patient management and is ongoing. Although a safe rechallenge with pembrolizumab was possible, treatment in the adjuvant setting is curative in intent and long-term safety follow-up is required to assess for delayed toxicity and long-term health implications. This is likely to require large regional/national/international databases to detect, monitor, and educate the wider medical community as these patients are followed up in primary care following initial specialist follow-up.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2022 ","pages":"2658136"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078828/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10252335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
A Nonseminomatous Germ Cell Tumor Presenting as a Mixed Cryoglobulinemic Vasculitis. 表现为混合性冷球蛋白血症性血管炎的非半细胞性生殖细胞肿瘤。
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2022-01-01 DOI: 10.1155/2022/3326761
Gabriel Cojuc-Konigsberg, Isabel Comte Natera, Blanca E López Graciano, Luis Gerardo Mosqueda López, José Alonso Rojo Ávila, Braulio Martínez, Juan C Ramírez-Sandoval
{"title":"A Nonseminomatous Germ Cell Tumor Presenting as a Mixed Cryoglobulinemic Vasculitis.","authors":"Gabriel Cojuc-Konigsberg,&nbsp;Isabel Comte Natera,&nbsp;Blanca E López Graciano,&nbsp;Luis Gerardo Mosqueda López,&nbsp;José Alonso Rojo Ávila,&nbsp;Braulio Martínez,&nbsp;Juan C Ramírez-Sandoval","doi":"10.1155/2022/3326761","DOIUrl":"https://doi.org/10.1155/2022/3326761","url":null,"abstract":"<p><strong>Background: </strong>Mixed cryoglobulinemia syndrome (MCS) is a rare entity with a variety of causes but has not been associated with testicular germ cell tumors. We present here a case of a patient with a nonseminomatous germ cell tumor (NSGCT) presenting as a type III mixed cryoglobulinemic vasculitis. <i>Case Presentation</i>. A 58-year-old male exhibited typical clinical features of vasculitis, including weakness, fatigue, palpable purpura, multiple mononeuropathy, and a low C4 level. An MCS diagnosis was confirmed by the presence of cryoglobulins (6%) with polyclonal IgM and IgG components and biopsy proven leukocytoclastic vasculitis. Concomitantly, a stage IIIC (TxNxM1bS1) germ tumor with marked elevation of serum beta-human chorionic gonadotropin (2764 mUI/mL) was diagnosed. An aggressive treatment was needed, including methylprednisolone pulses, plasmapheresis, rituximab, followed by orchiectomy, and chemotherapy (bleomycin/etoposide/cisplatin). After tumor resection and treatment, cryoglobulins decrease to 0%, suggesting a paraneoplastic origin of the vasculitis.</p><p><strong>Conclusion: </strong>To the best of our knowledge, this is the first case of MCS possibly attributable to a NSGCT. This case further elaborates on the presentation of mixed cryoglobulinemia vasculitis and adds to the published literature on the topic.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2022 ","pages":"3326761"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10467096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Systemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis. 全身贝伐单抗治疗严重复发性呼吸道乳头状瘤病。
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2022-01-01 DOI: 10.1155/2022/2767996
Swetha Tatineni, Zachary Warren, Mark A Applebaum, Fuad M Baroody
{"title":"Systemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis.","authors":"Swetha Tatineni,&nbsp;Zachary Warren,&nbsp;Mark A Applebaum,&nbsp;Fuad M Baroody","doi":"10.1155/2022/2767996","DOIUrl":"https://doi.org/10.1155/2022/2767996","url":null,"abstract":"<p><p>Recurrent respiratory papillomatosis (RRP) is the most common benign pediatric laryngeal neoplasm. Various adjuvant medical therapies have failed to reliably decrease surgical frequency in this challenging airway disease. Recently, systemic bevacizumab has shown promise in advanced, treatment-resistant papillomatosis. We describe the use of systemic bevacizumab in two children with severe RRP unresponsive to other therapies. Voice and breathing improved dramatically in both patients with minimal side effects. Both patients have not required surgery in 24 months and 16 months, respectively. Systemic bevacizumab is a promising long-term treatment for severe RRP, with oncology playing an important role in patient care.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2022 ","pages":"2767996"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10372150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Late Lung Metastasis in a Patient with a Clear Cell Chondrosarcoma: An Indication for a Life-Long Follow-Up? 透明细胞软骨肉瘤晚期肺转移:终身随访的指征?
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2021-12-02 eCollection Date: 2021-01-01 DOI: 10.1155/2021/7205649
Paulien West, Celine Jacobs, Michael Saerens, David Creytens, Gwen Sys, Lore Lapeire
{"title":"Late Lung Metastasis in a Patient with a Clear Cell Chondrosarcoma: An Indication for a Life-Long Follow-Up?","authors":"Paulien West,&nbsp;Celine Jacobs,&nbsp;Michael Saerens,&nbsp;David Creytens,&nbsp;Gwen Sys,&nbsp;Lore Lapeire","doi":"10.1155/2021/7205649","DOIUrl":"https://doi.org/10.1155/2021/7205649","url":null,"abstract":"<p><strong>Background: </strong>Clear cell chondrosarcoma (CCCS) is a rare subtype of chondrosarcoma and comprises between 1.6% and 2.5% of all chondrosarcoma. They are known to be chemo- and radiotherapy resistant; surgical resection is therefore the therapy of choice.</p><p><strong>Methods: </strong>We present a 63-year-old woman with a progressive lung nodule 20 years after initial diagnosis and treatment of a clear cell chondrosarcoma of the right os naviculare.</p><p><strong>Results: </strong>On serial CT scans of the chest, an asymptomatic, slowly growing nodule in the left upper lung lobe was detected. CT-guided transthoracic biopsy of this nodule confirmed the diagnosis of a chondrosarcoma lung metastasis. Video-assisted thoracoscopic wedge resection was performed with complete removal of the nodule. The patient recovered well from surgery and remains in good health during further follow-up.</p><p><strong>Conclusion: </strong>Given the tendency of clear cell chondrosarcoma to recur and metastasize after extended periods of time, a long-term, possibly life-long follow-up and clinical surveillance is advisable in these patients.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2021 ","pages":"7205649"},"PeriodicalIF":0.9,"publicationDate":"2021-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39719713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Intraosseous Synovial Sarcoma in the Mandible. 下颌骨原发性骨内滑膜肉瘤
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2021-11-28 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9945591
Lucas Novaes Teixeira, Eduardo Zambaldi da Cruz, Ana Cláudia Garcia Rosa, Anderson Abdo Rodrigues, Fabrício Passador-Santos, Vera Cavalcanti de Araújo, Andresa Borges Soares
{"title":"Primary Intraosseous Synovial Sarcoma in the Mandible.","authors":"Lucas Novaes Teixeira, Eduardo Zambaldi da Cruz, Ana Cláudia Garcia Rosa, Anderson Abdo Rodrigues, Fabrício Passador-Santos, Vera Cavalcanti de Araújo, Andresa Borges Soares","doi":"10.1155/2021/9945591","DOIUrl":"10.1155/2021/9945591","url":null,"abstract":"<p><p>Synovial sarcoma (SS) is a rare malignant mesenchymal tumor that mainly occurs in body extremities, being uncommon in the head and neck region. In the present study, we described a case of primary intraosseous SS arising in the mandible of a 22-year-old young male. The patient reported a painful swelling on the left side of the mandible for the last 7 months. Imaging exams showed the presence of an expansive and multilocular radiolucent lesion, extending from the left condyle to the mandibular body. The clinic diagnostic hypotheses were ameloblastoma or malignant neoplasm. Histologically, the lesion was characterized by a proliferation of spindle cells exhibiting vesicular nuclei and evident nucleolus. Neoplastic cells were positive for AE1/AE3, cytokeratin 7, vimentin, CD-99, and TLE-1 and negative for CD-34, S-100, SMA, and HHF-35. A combination of clinical, histologic, and immunohistochemical characteristics supported the diagnosis of SS. The patient was referred for treatment, and preoperative exams did not reveal any other tumor foci in the body of the patient. The final diagnosis was of a primary intraosseous SS of the mandible.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2021 ","pages":"9945591"},"PeriodicalIF":0.9,"publicationDate":"2021-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39701290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL). 急性淋巴细胞白血病(ALL)的心包复发。
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2021-11-25 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9953230
Diana V Maslov, Ambuga Badari
{"title":"Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL).","authors":"Diana V Maslov,&nbsp;Ambuga Badari","doi":"10.1155/2021/9953230","DOIUrl":"https://doi.org/10.1155/2021/9953230","url":null,"abstract":"<p><p>Acute lymphoblastic leukemia (ALL) is a neoplasm of the B cell or T cell. Diagnosis is made by peripheral blood smear and bone marrow biopsy. Those with relapse/measurable residual disease (MRD) present with fever, weakness, fatigue, and easy bruising due to bone marrow infiltration (Kantarjian et al., 2017). A 59-year-old male with history of relapsed acute lymphoblastic leukemia and allogeneic stem cell transplant presented to the Emergency Department (ED) multiple times with shortness of breath. 2D Echo revealed recurrent pericardial effusion. His MRD was discovered in the pericardium. He underwent the creation of a pericardial window with cytology and culture which confirmed B cell lymphoblastic leukemia/lymphoma, consistent with relapsed disease. We present a case of a patient with B-ALL and MRD who presented with symptoms of shortness of breath. His MRD was discovered not in the bone marrow, but in the pericardium.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2021 ","pages":"9953230"},"PeriodicalIF":0.9,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39572473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recurrent Solitary Fibrous Tumor in Intradural Extramedullary Space: Case Report and Review of the Literature. 硬膜内髓外间隙复发孤立性纤维性肿瘤:1例报告及文献复习。
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2021-11-20 eCollection Date: 2021-01-01 DOI: 10.1155/2021/4559749
Neris Dincer, Melisa Bagci, Metin Figen, Adem Yilmaz, Ahmet Mesrur Halefoglu, Canan Tanik, Esengul Kocak Uzel
{"title":"Recurrent Solitary Fibrous Tumor in Intradural Extramedullary Space: Case Report and Review of the Literature.","authors":"Neris Dincer,&nbsp;Melisa Bagci,&nbsp;Metin Figen,&nbsp;Adem Yilmaz,&nbsp;Ahmet Mesrur Halefoglu,&nbsp;Canan Tanik,&nbsp;Esengul Kocak Uzel","doi":"10.1155/2021/4559749","DOIUrl":"https://doi.org/10.1155/2021/4559749","url":null,"abstract":"<p><p>Solitary fibrous tumor/hemangiopericytoma (SFT/HPC) is a rare neoplasm arising from spindle cells and most commonly arising from pleura. Spinal SFT/HPC is a rare entity; hence, it is not on the top of the differential diagnosis list when a clinician faces a spinal lesion. In the review of the literature, there exist less than 50 case reports of intradural extramedullary SFT/HPC. Here, we present a 54-year-old female patient who underwent subtotal surgical excision of an intradural extramedullary spinal mass pathologically reported to be SFT/HPC and had symptomatic recurrence in the 3<sup>rd</sup> year of follow-up. Surgical intervention was unachievable and the patient was given 45 Gy to the surgical cavity followed by a 5.4 Gy boost to visible tumor with external radiotherapy. Patient reported significant relief of her symptoms. We aim to contribute to the formation of a treatment algorithm for this rare entity.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2021 ","pages":"4559749"},"PeriodicalIF":0.9,"publicationDate":"2021-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39677817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Atypical Presentation of Sinonasal Tract Alveolar Rhabdomyosarcoma in a Young Male Patient Submitted to Multimodality Treatment. 一位接受多种治疗的年轻男性患者以不典型的表现表现鼻道肺泡横纹肌肉瘤。
IF 0.9
Case Reports in Oncological Medicine Pub Date : 2021-10-31 eCollection Date: 2021-01-01 DOI: 10.1155/2021/8401755
Wilber E Bernaola-Paredes, Sergio Leonardo Favareto, Valdener Bella Filho, Eloah Pascuotte Filippetti, Walkiria Pantoja Bellotto, Henrique Rocha Mazorchi Veronese, Lucas Neves de Martins Moraes, Felipe D'Almeida Costa, Antonio Cassio Assis Pellizzon
{"title":"An Atypical Presentation of Sinonasal Tract Alveolar Rhabdomyosarcoma in a Young Male Patient Submitted to Multimodality Treatment.","authors":"Wilber E Bernaola-Paredes,&nbsp;Sergio Leonardo Favareto,&nbsp;Valdener Bella Filho,&nbsp;Eloah Pascuotte Filippetti,&nbsp;Walkiria Pantoja Bellotto,&nbsp;Henrique Rocha Mazorchi Veronese,&nbsp;Lucas Neves de Martins Moraes,&nbsp;Felipe D'Almeida Costa,&nbsp;Antonio Cassio Assis Pellizzon","doi":"10.1155/2021/8401755","DOIUrl":"https://doi.org/10.1155/2021/8401755","url":null,"abstract":"<p><p>Rhabdomyosarcoma (RMS), a malignant tumor derived from the neoplastic proliferation of striated skeletal muscle cells, is the most common pediatric soft tissue sarcoma. Its treatment is mainly based on neoadjuvant chemotherapy (QT+), surgical resection, and adjuvant radiotherapy (RT+). RT+ has shown satisfactory results for locoregional control of the disease, in spite of promoting local side effects. The present case report was aimed at describing the clinical and therapeutic characteristics and the management of complications resulting from multimodal therapy in a patient with an atypical presentation of RMS in the sinonasal tract. A 20-year-old Afro-descendant man complained of an expansive tumor lesion, with left eye proptosis that reduced visual acuity and caused severe regional pain. Imaging analysis showed an extensive and infiltrative lesion in the periorbital region, sinonasal tract, left maxilla, and orbital roof. According to the histopathological analysis, the diagnosis was established corresponding to parameningeal alveolar RMS that was unresectable. Treatment was initiated with three cycles of QT+ which showed partial response and later RT+. After completing half of the RT+ sessions, the patient showed a complete response with reduction in tumor volume and improvement in pain and local conditions. Side effects such as alopecia and dermatological changes induced by radiation were observed. Moreover, painful erythematous areas were observed in the region of the hard and soft palate, uvula, and oropharynx, compatible with Grade 2 mucositis lesions. After the cytological swab test, some of them were diagnosed as herpes simplex lesions; thickening and decrease in salivary flow were also found. A local drug therapy approach was instituted, and photobiomodulation was performed to manage oral complications. RT+ was shown to be effective in locoregional control of the disease; however, the early management of its undesirable effects on the surrounding tissues was required.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2021 ","pages":"8401755"},"PeriodicalIF":0.9,"publicationDate":"2021-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39711871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信